61 related articles for article (PubMed ID: 19148539)
1. Molecular dissection of human oncostatin M-mediated signal transductions through site-directed mutagenesis.
Liu H; Fenollar-Ferrer C; Cao A; Anselmi C; Carloni P; Liu J
Int J Mol Med; 2009 Feb; 23(2):161-72. PubMed ID: 19148539
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
[TBL] [Abstract][Full Text] [Related]
3. Delineating an oncostatin M-activated STAT3 signaling pathway that coordinates the expression of genes involved in cell cycle regulation and extracellular matrix deposition of MCF-7 cells.
Zhang F; Li C; Halfter H; Liu J
Oncogene; 2003 Feb; 22(6):894-905. PubMed ID: 12584569
[TBL] [Abstract][Full Text] [Related]
4. STAT3 and ERK Signaling Pathways Are Implicated in the Invasion Activity by Oncostatin M through Induction of Matrix Metalloproteinases 2 and 9.
Ko HS; Park BJ; Choi SK; Kang HK; Kim A; Kim HS; Park IY; Shin JC
Yonsei Med J; 2016 May; 57(3):761-8. PubMed ID: 26996579
[TBL] [Abstract][Full Text] [Related]
5. Janus kinase activation by cytokine oncostatin M decreases PCSK9 expression in liver cells.
Cao A; Wu M; Li H; Liu J
J Lipid Res; 2011 Mar; 52(3):518-30. PubMed ID: 21196532
[TBL] [Abstract][Full Text] [Related]
6. STAT1 and STAT3 do not participate in FGF-mediated growth arrest in chondrocytes.
Krejci P; Salazar L; Goodridge HS; Kashiwada TA; Schibler MJ; Jelinkova P; Thompson LM; Wilcox WR
J Cell Sci; 2008 Feb; 121(Pt 3):272-81. PubMed ID: 18198189
[TBL] [Abstract][Full Text] [Related]
7. The interleukin-6-type cytokine oncostatin M induces aryl hydrocarbon receptor expression in a STAT3-dependent manner in human HepG2 hepatoma cells.
Stobbe-Maicherski N; Wolff S; Wolff C; Abel J; Sydlik U; Frauenstein K; Haarmann-Stemmann T
FEBS J; 2013 Dec; 280(24):6681-90. PubMed ID: 24127753
[TBL] [Abstract][Full Text] [Related]
8. Induction of low density lipoprotein receptor (LDLR) transcription by oncostatin M is mediated by the extracellular signal-regulated kinase signaling pathway and the repeat 3 element of the LDLR promoter.
Li C; Kraemer FB; Ahlborn TE; Liu J
J Biol Chem; 1999 Mar; 274(10):6747-53. PubMed ID: 10037774
[TBL] [Abstract][Full Text] [Related]
9. Are STATS arginine-methylated?
Komyod W; Bauer UM; Heinrich PC; Haan S; Behrmann I
J Biol Chem; 2005 Jun; 280(23):21700-5. PubMed ID: 15826948
[TBL] [Abstract][Full Text] [Related]
10. Blockage of oncostatin M-induced LDL receptor gene transcription by a dominant-negative mutant of C/EBPbeta.
Zhou Y; Zhang F; Abidi P; Lin M; Thiel G; Liu J
Biochem J; 2006 Jul; 397(1):101-8. PubMed ID: 16563127
[TBL] [Abstract][Full Text] [Related]
11. MEK/ERK and signal transducer and activator of transcription signaling pathways modulate oncostatin M-stimulated CCL2 expression in human osteoblasts through a common transcription factor.
Lin SK; Kok SH; Yeh FT; Kuo MY; Lin CC; Wang CC; Goldring SR; Hong CY
Arthritis Rheum; 2004 Mar; 50(3):785-93. PubMed ID: 15022320
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional activation of c-Fos by constitutively active Galpha(16)QL through a STAT1-dependent pathway.
Lo RK; Wong YH
Cell Signal; 2006 Dec; 18(12):2143-53. PubMed ID: 16781847
[TBL] [Abstract][Full Text] [Related]
13. Leukemia inhibitory factor can mediate Ras/Raf/MEK/ERK-induced growth inhibitory signaling in medullary thyroid cancer cells.
Arthan D; Hong SK; Park JI
Cancer Lett; 2010 Nov; 297(1):31-41. PubMed ID: 20570039
[TBL] [Abstract][Full Text] [Related]
14. Induction of Egr-1 by oncostatin M precedes up-regulation of low density lipoprotein receptors in HepG2 cells.
Liu J; Shoyab M; Grove RI
Cell Growth Differ; 1993 Jul; 4(7):611-6. PubMed ID: 8398902
[TBL] [Abstract][Full Text] [Related]
15. Oncostatin M-induced CCL2 transcription in osteoblastic cells is mediated by multiple levels of STAT-1 and STAT-3 signaling: an implication for the pathogenesis of arthritis.
Kok SH; Hong CY; Kuo MY; Wang CC; Hou KL; Lin YT; Galson DL; Lin SK
Arthritis Rheum; 2009 May; 60(5):1451-62. PubMed ID: 19404962
[TBL] [Abstract][Full Text] [Related]
16. Oncostatin M suppresses metastasis of lung adenocarcinoma by inhibiting SLUG expression through coordination of STATs and PIASs signalings.
Pan CM; Wang ML; Chiou SH; Chen HY; Wu CW
Oncotarget; 2016 Sep; 7(37):60395-60406. PubMed ID: 27486982
[TBL] [Abstract][Full Text] [Related]
17. Blockage of the ERK signaling pathway abrogates the SCAP ligand-induced transcriptional activation of the LDL receptor gene in HepG2 cells.
Abidi P; Zhang F; Li C; Liu J
Int J Mol Med; 2005 Nov; 16(5):779-85. PubMed ID: 16211244
[TBL] [Abstract][Full Text] [Related]
18. Induction of S100A9 gene expression by cytokine oncostatin M in breast cancer cells through the STAT3 signaling cascade.
Li C; Zhang F; Lin M; Liu J
Breast Cancer Res Treat; 2004 Sep; 87(2):123-34. PubMed ID: 15377837
[TBL] [Abstract][Full Text] [Related]
19. Novel mechanism of transcriptional activation of hepatic LDL receptor by oncostatin M.
Liu J; Streiff R; Zhang YL; Vestal RE; Spence MJ; Briggs MR
J Lipid Res; 1997 Oct; 38(10):2035-48. PubMed ID: 9374126
[TBL] [Abstract][Full Text] [Related]
20. Receptor-mediated tobacco toxicity: cooperation of the Ras/Raf-1/MEK1/ERK and JAK-2/STAT-3 pathways downstream of alpha7 nicotinic receptor in oral keratinocytes.
Arredondo J; Chernyavsky AI; Jolkovsky DL; Pinkerton KE; Grando SA
FASEB J; 2006 Oct; 20(12):2093-101. PubMed ID: 17012261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
